ArticleTranslational cancer research2020
Sclerosing thymoma: a case report and literature review.
Article in Translational cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
- Non-IgG4-Related Fibrosing Mediastinitis Diagnosed on Core Needle Biopsy and Treated with Steroids: A Case Study and Review of the Differential Diagnoses.International journal of surgical pathology · 2024Review
- Epigenetics of Thymic Epithelial Tumors.Cancers · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sclerosing thymoma is an exceedingly rare form of thymoma. Since its first documentation in 1994, we have retrieved only 16 records from PUBMED. All these tumors exhibited a noninvasive growth pattern. A 53-year-old man, presenting only with mild dyspnea, was referred to our hospital owing to a soft tissue mass, measuring 4.3×2.5 cm. Microscopic examination led to a final diagnosis of sclerosing thymoma, unexpectedly invading the left brachiocephalic vein. Adjuvantly, the tumor bed received a radiation dose of 95% PTV 50 Gy with conventional fractionation. No sign of local recurrence appeared on a 2-year follow-up computed tomography (CT) scan. Sclerosing thymoma is a rare type of thymoma, and the pathological manifestations are prominent hyalinization and sclerosis, which make the neoplastic areas not obvious, making the diagnosis of the disease difficult. Previously, the disease was considered non-invasive, which may need to be changed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.